Taking a Closer Look At Denali Therapeutics Inc (DNLI) Following Its Recent Trade
In a filing, Denali Therapeutics Inc revealed its Director SATO VICKI L unloaded Company’s shares for reported $30471.0 on Apr
In a filing, Denali Therapeutics Inc revealed its Director SATO VICKI L unloaded Company’s shares for reported $30471.0 on Apr
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Denali Therapeutics Inc’s filing revealed that its Director SATO VICKI L unloaded Company’s shares for reported $30471.0 on Apr 15
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Denali Therapeutics Inc’s recent filing unveils that its Director Krognes Steve E. unloaded Company’s shares for reported $1.9 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Denali Therapeutics
Denali Therapeutics Inc’s filing revealed that its Director Krognes Steve E. unloaded Company’s shares for reported $1.9 million on Apr
Denali Therapeutics Inc. (NASDAQ:DNLI) does about 640.18K shares in volume on a normal day but saw 472397 shares change hands